Solution-oriented thinking, flexibility and a high-degree of specialization is not just a promise, it's in our DNA!
CEO & Managing Partner
Juergen Mairhofer, PhD
Juergen co-founded enGenes Biotech after working as a Research Associate at the intersection of genetic and bioprocess engineering at the University of Natural Resources and Life Sciences (BOKU), Vienna, Austria. Prior to this, he held a PostDoc position at the Austrian Centre of Industrial Biotechnology (ACIB GmbH.), working in the research field “Microbial Cell Design” were he was involved in the sequencing and engineering of different host strains for the production of recombinant proteins. He has authored several peer-reviewed scientific publications and book chapters and received trainings from the University of Iceland (Systems Biology / Genome-scale stoechiometric modeling) and the University of Bielefeld (Microbial Genomics & Transcriptomics).
Juergen holds a PhD in Biotechnology from the University of Natural Resources and Life Sciences, Vienna, Austria.
Successfully patented
enGenes has been a highly flexible specialist in developing scalable bioprocesses for cost-effective production of recombinant proteins in Escherichia coli since 2014, utilizing its patented technologies and a team of highly experienced and motivated scientists.
Innovative development pipeline
enGenes Biotech's commitment to ongoing internal developments has led to continuous improvements to the enGenes-eXpress core technology, resulting in meaningful extensions and expanding our technological capabilities. Our dedication is to push the boundaries of innovation in the field of biotechnology.
Sound intellectual property position
enGenes Biotech's sound IP portfolio, which includes patented technologies and trade secrets, provides a significant competitive advantage for customers by ensuring the protection of their products, processes, and technologies, ultimately leading to greater market success and profitability.
Owner-managed and customer-centric
As an owner-managed company, enGenes Biotech has a strong focus on the success of its clients and can act quickly and flexibly to meet their needs, which is a significant advantage for customers who require tailored solutions and customized services. Your success is our compass, guiding every innovative stride.
Scientific Advisor & Co-Founder
Gerald Striedner, PhD
Gerald is currently full time Professor for bioprocess engineering at the University of Natural Resources and Life Sciences, Vienna, Austria. He is head of the microbial fermentation group at the Department of Biotechnology and has authored more than 30 peer-reviewed publications and book chapters. Additionally, he is listed as an inventor on more than 5 patent applications. His research activities include process analytical technology (PAT), bioprocess optimization and systems biology.
CFO & Managing Partner
Peter Hacker
Peter has over 25 years of experience in various national and international financial positions in banks, corporations, private equity firms, and early-stage companies. In his current role he is contributing considerably to the present and future growth of the company.
Business Development, ext. Consultant
Karl Huebler, PhD
Karl has over 30 years of experience in the pharma and biotech business. He is leading the Business development team and is responsible for contracts and legal issues.
Non-Executive Director
Urs Spitz, PhD
Urs is a senior manager, scientist, entrepreneur, and investor. Urs gained extensive professional experience at Bain & Company and Mettler-Toledo. Since 2005, he has grown Biosynth from a tiny Swiss chemical shop into a leading international supplier of critical raw materials for the life science industry. He is a co-founder, business angel, advisor, and board member supporting many chemical and biotech companies
Senior Bioprocess Scientist
Patrick Stargardt, PhD
Patrick is a professional with over 9 years of experience in the field of Bioprocessing. He is co-responsible for the business development and scientific lead of the upstream process development team at enGenes Biotech.
Senior Bioprocess Scientist
Markus Berg, PhD
Markus is a bioprocessing specialist with over six years of experience in downstream process development. He focuses on optimizing primary and secondary product recovery in (continuous-) bioprocessing, working across micro-, lab-, and pilot-scale systems. Through collaboration with industry and academia, he develops scalable downstream processes for biopharmaceutical production.
Senior Bioprocess Scientist
Natalia Danielewicz, PhD
Natalia is an analytical bioprocess developer with experience in the design, production, purification, and application of proteins. Dedicated to creating custom-driven recombinant proteins that solve the most challenging problems using cutting-edge technologies.
Senior Bioprocess Scientist
Florian Weiß, MSc
Florian is an experienced bioprocess professional. His experience is mainly in the upstream development of pDNA and recombinant protein production processes as well as in product analytics.
Junior Bioprocess Scientist
Carina Eschenbach, MSc
Carina holds a Master's degree in Biotechnology with a specialization in
Bioprocess Engineering. With extensive laboratory experience, she
specializes in optimizing fermentation processes for the production of
recombinant proteins. Her work focuses on improving E. coli through
molecular engineering while also refining key process parameters to
enhance efficiency and yield.
Junior Bioprocess Scientist / PhD candidate
Florian Simon, MSc
Florian graduated in Biotechnology. He is an experienced scientist in molecular cell engineering, recombinant protein production and Upstream processing. Currently he is working on his PhD where he is developing continuous Bioprocesses using E. coli.
Office Manager / Administration
Katarina Kostolanska
Katarina has previously worked as Office Manager for an austrian IT Company for more than 6 years. At enGenes, she is responsible for all administration matters, HR agenda and supports the finance department.
Intern
Maelle Krut, BSc
Maelle is eagerly working towards her Master’s degree in Bioengineering and is currently working at enGenes on the production of protein A variants. When she is not at work, she enjoys nature, hiking in the mountains and climbing or cooking.
A team full of competence and passion
enGenes has been a highly flexible specialist in developing scalable bioprocesses for cost-effective production of recombinant proteins in Escherichia coli since 2014, utilizing its patented technologies and a team of highly experienced and motivated scientists.